If it sounds too good to be true, its because it is
Insulin plays a major role in maintaining brain homeostasis and regulating its physiological functions

Key disclosures from company terms include: MEDVi states it does not directly provide medical or pharmacy services Payment does not guarantee the writing or dispensing of a prescription The site identifies itself as "an advertisement for services and not any specific medication" OpenLoop Health clinicians retain the decision to prescribe compounded GLP-1s to patients Entity Structure According to MEDVi's terms of use: "MEDVi does not provide any Healthcare Services through the Platform and is not licensed to practice medicine." MEDVi, LLC: Technology platform providing intake coordination, customer service, and payment processing OpenLoop Health: According to company disclosures, provides the network of licensed medical providers who conduct evaluations and make prescribing decisions Partner compounding pharmacies: According to the website, MEDVi partners with "multiple USA certified pharmacies" Pricing (As of December 26, 2025) Cost considerations are separate from medical appropriateness and should not influence prescribing decisions

Providers may prescribe compounded drugs as needed to meet patient requirements or drug shortages
Clinical trials indicate hair loss in about 4-5% of tirzepatide users and 3% of semaglutide users, but real-world data and experience suggests a much higher risk, particularly in women